Evolus - Stock Price History | EOLS

Historical daily share price chart and data for Evolus since 2020 adjusted for splits. The latest closing stock price for Evolus as of May 28, 2020 is 5.30.
  • The all-time high Evolus stock closing price was 38.49 on June 06, 2018.
  • The Evolus 52-week high stock price is 20.27, which is 282.5% above the current share price.
  • The Evolus 52-week low stock price is 3.12, which is 41.1% below the current share price.
  • The average Evolus stock price for the last 52 weeks is 11.71.
Evolus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 17.9324 12.4300 28.9100 11.5800 12.1700 2.27%
2018 16.8620 11.5000 38.4900 6.8500 11.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.174B $0.035B
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $160.540B 27.84
Medtronic (MDT) Ireland $128.656B 20.92
Stryker (SYK) United States $71.825B 23.31
Boston Scientific (BSX) United States $51.972B 24.43
Baxter (BAX) United States $43.843B 26.76
Lonza Group Ag (LZAGY) Switzerland $35.618B 0.00
Terumo (TRUMY) Japan $28.824B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.490B 16.67
ResMed (RMD) United States $22.237B 35.09
Smith & Nephew SNATS (SNN) United Kingdom $17.941B 0.00
Sunny Optical Technology (SNPTF) China $14.851B 0.00
Bio-Rad Laboratories (BIO) United States $13.955B 63.53
Insulet (PODD) United States $11.256B 1115.19
Perrigo (PRGO) Ireland $7.569B 13.54
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Canopy Growth (CGC) Canada $6.981B 0.00
Quidel (QDEL) United States $6.614B 51.98
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Hill-Rom Holdings (HRC) United States $6.576B 18.54
William Demant Holdings (WILYY) Denmark $6.552B 0.00
Haemonetics (HAE) United States $5.498B 33.02
ICU Medical (ICUI) United States $4.106B 29.95
GW Pharmaceuticals (GWPH) United Kingdom $3.911B 0.00
Neogen (NEOG) United States $3.835B 64.96
Agios Pharmaceuticals (AGIO) United States $3.654B 0.00
Envista Holdings (NVST) United States $3.387B 0.00
NuVasive (NUVA) United States $3.256B 26.15
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.660B 0.00
National Vision Holdings (EYE) United States $2.289B 39.60
TG Therapeutics (TGTX) United States $2.262B 0.00
AtriCure (ATRC) United States $1.987B 0.00
Aurora Cannabis (ACB) Canada $1.552B 0.00
Cardiovascular Systems (CSII) United States $1.373B 0.00
MacroGenics (MGNX) United States $1.137B 0.00
Aphria (APHA) Canada $1.120B 0.00
NanoString Technologies (NSTG) United States $1.111B 0.00
Phibro Animal Health (PAHC) United States $1.070B 21.33
Cerus (CERS) United States $0.976B 0.00
PetIQ (PETQ) United States $0.873B 25.20
InMode (INMD) Israel $0.851B 17.99
OraSure Technologies (OSUR) United States $0.846B 170.38
Omeros (OMER) United States $0.830B 0.00
VAREX IMAGING (VREX) United States $0.769B 19.09
Quanterix (QTRX) United States $0.757B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.756B 127.92
Eagle Pharmaceuticals (EGRX) United States $0.731B 52.36
Zynex (ZYXI) United States $0.612B 61.50
Meridian Bioscience (VIVO) United States $0.599B 22.57
LeMaitre Vascular (LMAT) United States $0.552B 31.44
Lantheus Holdings (LNTH) United States $0.549B 11.05
Surmodics (SRDX) United States $0.532B 64.15
Vapotherm (VAPO) United States $0.530B 0.00
Owens & Minor (OMI) United States $0.486B 12.87
Repro-Med Systems (KRMD) United States $0.377B 316.67
Utah Medical Products (UTMD) United States $0.352B 25.59
Cytosorbents (CTSO) United States $0.352B 0.00
BioLife Solutions (BLFS) United States $0.331B 147.09
Viemed Healthcare (VMD) United States $0.309B 27.69
Organigram Holdings (OGI) Canada $0.297B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.294B 0.00
HEXO (HEXO) $0.276B 0.00
Female Health (VERU) United States $0.241B 0.00
InfuSystems Holdings (INFU) United States $0.221B 122.22
Chimerix (CMRX) United States $0.218B 0.00
Chembio Diagnostics (CEMI) United States $0.172B 0.00
Exagen (XGN) United States $0.157B 0.00
Bovie Medical (APYX) United States $0.152B 0.00
Fonar (FONR) United States $0.149B 13.24
Rockwell Medical (RMTI) United States $0.148B 0.00
MTech Acquisition (KERN) United States $0.137B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Surface Oncology (SURF) United States $0.133B 0.00
Liberty Health Sciences (LHSIF) Canada $0.132B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.121B 0.00
Brainsway (BWAY) Israel $0.085B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.076B 0.00
Wound Management Technologies (SMTI) United States $0.076B 0.00
United-Guardian (UG) United States $0.073B 16.93
Nephros (NEPH) United States $0.068B 0.00
Capricor Therapeutics (CAPR) United States $0.068B 0.00
GUARDION HEALTH (GHSI) United States $0.043B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00